日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trial

伊帕罗利单抗和图沃拉利单抗（QL1706）联合根治性放化疗治疗局部晚期食管鳞状细胞癌患者（QL1706-IIT-02）：一项单臂 II 期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103758
Zhang, Wencheng; Zhang, Tian; Chen, Xi; Li, Jiacheng; Gao, Linrui; Jiang, Shengpeng; Wang, Yufei; Zheng, Zhunhao; Dong, Jie; Li, Zewei; Zhao, Gang; Cao, Fuliang; Bai, Na; Wang, Ping; Yan, Cihui; Pang, Qingsong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial

替雷利珠单抗联合同步放化疗与单纯同步放化疗治疗老年不可手术局部晚期食管鳞状细胞癌患者：一项多中心、随机、平行对照的II期临床试验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13758-0
Zhang, Ke; Wang, Qifeng; Cao, Jianzhong; Fan, Chengcheng; Shen, Wenbin; Xiao, Qin; Ge, Xiaolin; Zhang, Tian; Liu, Xiao; Chen, Xi; Dong, Jie; Li, Zewei; Zheng, Zhunhao; Yan, Cihui; Wang, Ping; Pang, Qingsong; Zhang, Wencheng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and safety of radiotherapy in first-line treatment for de novo advanced esophageal cancer in the era of immunochemotherapy: a systematic review and meta-analysis

免疫化疗时代，放射疗法一线治疗新发晚期食管癌的疗效和安全性：系统评价和荟萃分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-15420-1
Zeng, Hai; Wu, Yan-Ling; Wang, Xiaofeng; Bai, Hui; Yan, Cihui; Zhang, Wencheng; Wang, Qifeng
食管癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Correction: In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma

更正：体外 CRISPR 筛选发现 CRTC3 是 IFN-γ 诱导的肝细胞癌铁死亡的调节因子

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-023-01745-y
Li, Li; Xing, Tao; Chen, Yiran; Xu, Weiran; Fan, Bo; Ju, Gaoda; Zhao, Jing; Lin, Li; Yan, Cihui; Liang, Jun; Ren, Xiubao
肿瘤
肿瘤免疫
铁死亡
IFN-γ
细胞生物学
发表日期：2023
文献求助 收藏

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study

在局部晚期食管鳞状细胞癌患者中，卡瑞利珠单抗联合多西他赛、顺铂和放射治疗：一项 1b 期研究

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2021.1971418
Zhang, Wencheng; Yan, Cihui; Zhang, Tian; Chen, Xi; Dong, Jie; Zhao, Jingjing; Han, Dong; Wang, Jun; Zhao, Gang; Cao, Fuliang; Zhou, Dejun; Jiang, Hongjing; Tang, Peng; Zhao, Lujun; Yuan, Zhiyong; Wang, Quanren; Wang, Ping; Pang, Qingsong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade.

树突状细胞和巨噬细胞在接受放化疗和 PD-1 阻断联合治疗的食管癌中的空间分布及其预测意义

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.786429
Ma Xiaoxue, Guo Zhoubo, Wei Xiaoying, Zhao Gang, Han Dong, Zhang Tian, Chen Xi, Cao Fuliang, Dong Jie, Zhao Lujun, Yuan Zhiyong, Wang Ping, Pang Qingsong, Yan Cihui, Zhang Wencheng
细胞生物学
发表日期：2021
文献求助 收藏

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma

放疗联合卡瑞利珠单抗治疗局部晚期食管鳞状细胞癌的安全性和可行性

期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13797
Zhang, Wencheng; Yan, Cihui; Gao, Xuan; Li, Xiaoxia; Cao, Fuliang; Zhao, Gang; Zhao, Jingjing; Er, Puchun; Zhang, Tian; Chen, Xi; Wang, Yuwen; Jiang, Yao; Wang, Quanren; Zhang, Baozhong; Qian, Dong; Wang, Jun; Zhou, Dejun; Ren, Xiubao; Yu, Zhentao; Zhao, Lujun; Yuan, Zhiyong; Wang, Ping; Pang, Qingsong
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells

抗CD47抗体作为人类肺癌和癌症干细胞的靶向治疗药物

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2017.00404
Liu, Liang; Zhang, Lin; Yang, Lin; Li, Hui; Li, Runmei; Yu, Jinpu; Yang, Lili; Wei, Feng; Yan, Cihui; Sun, Qian; Zhao, Hua; Yang, Fan; Jin, Hao; Wang, Jian; Wang, Shizhen Emily; Ren, Xiubao
肺癌
肿瘤
发育与干细胞
T细胞
肿瘤免疫
CD47
Human
干细胞
细胞生物学
CD4
发表日期：2017
文献求助 收藏